Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Agile Therapeutics Inc    AGRX

AGILE THERAPEUTICS INC (AGRX)
Mes dernières consult.
Most popular
Report
Delayed Quote. Delayed  - 12/15 10:00:00 pm
4.77 USD   +5.07%
11/06 AGILE THERAPEUT : reports 3Q loss
11/06 Agile Therapeutics Reports Third Quarter 2017 Financial Results
11/03 AGILE THERAPEUT : AGRX) Files An 8-K Other Events
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
12/11/2017 12/12/2017 12/13/2017 12/14/2017 12/15/2017 Date
4.95(c) 4.86(c) 4.71(c) 4.54(c) 4.77(c) Last
379 085 302 514 204 620 408 675 487 050 Volume
+5.77% -1.82% -3.09% -3.61% +5.07% Change
More quotes
Financials ($)
Sales 2017 -
EBIT 2017 -28,6 M
Net income 2017 -30,2 M
Debt 2017 -
Yield 2017 -
Sales 2018 19,6 M
EBIT 2018 -34,6 M
Net income 2018 -33,8 M
Debt 2018 -
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
Capi. / Sales2017 0
Capi. / Sales2018 8,33x
Capitalization 163 M
More Financials
Company
Agile Therapeutics, Inc. engages in the development and commercialization of new prescription contraceptive products.Its product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance.The company was founded on December 22, 1997... 
More about the company
Surperformance© ratings of Agile Therapeutics Inc
Trading Rating : Investor Rating : -
More Ratings
Latest news on AGILE THERAPEUTICS INC
11/09 AGILE THERAPEUTICS : Presents Additional Phase 3 SECURE Trial Results for Twirla..
11/06 AGILE THERAPEUTICS : Management's Discussion and Analysis of Financial Condition..
11/06 AGILE THERAPEUTICS INC : Results of Operations and Financial Condition, Financia..
11/06 AGILE THERAPEUTICS : reports 3Q loss
11/06 Agile Therapeutics Reports Third Quarter 2017 Financial Results
11/03 AGILE THERAPEUTICS,INC. (NASDAQ : AGRX) Files An 8-K Other Events
11/03 AGILE THERAPEUTICS INC : Other Events, Financial Statements and Exhibits (form 8..
11/02 AGILE THERAPEUTICS : Presents Additional Phase 3 SECURE Trial Results for Twirla..
10/31 AGILE THERAPEUTICS : Presents Additional Phase 3 SECURE Trial Results for Twirla..
10/26 AGILE THERAPEUTICS : Presents Additional Twirla® Phase 3 SECURE Study Results at..
More news
Sector news : Bio Therapeutic Drugs
12/15DJSTOCKS TO WATCH : CSX, Aclaris, Alnylam, Rigel
12/15DJALNYLAM PHARMACEUTICALS : Stock Rises as FDA Lifts Study Hold
12/13 France's Sanofi pins hopes on new drugs after setbacks
12/12 Sanofi investors hungry for drug progress and deal news
12/09 Tax-loss selling to pressure 2017's losers in December
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
11/06 Agile Therapeutics beats by $0.03
10/15 WEEK 42 BREAKOUT FORECAST : Short-Term Picks To Give You An Edge
10/11 Agile Therapeutics (AGRX) Investor Presentation - Slideshow
10/08 WEEK 41 BREAKOUT FORECAST : Short-Term Picks To Give You An Edge
10/02 Premarket analyst action - healthcare
Chart AGILE THERAPEUTICS INC
Duration : Period :
Agile Therapeutics Inc Technical Analysis Chart | AGRX | US00847L1008 | 4-Traders
Technical analysis trends AGILE THERAPEUTICS INC
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Average target price 11,2 $
Spread / Average Target 135%
EPS Revisions
Managers
NameTitle
Alfred F. Altomari President, Chief Executive Officer & Director
Scott M. Coiante Chief Financial Officer & Vice President
Elizabeth Ijeoma Onyemelukwe Garner Chief Medical Officer & Senior Vice President
Abhijeet J. Lele Independent Director
William T. McKee Director
Sector and Competitors
1st jan.Capitalization (M$)
AGILE THERAPEUTICS INC-20.35%163
GILEAD SCIENCES6.94%98 689
REGENERON PHARMACEUTICALS5.33%41 789
VERTEX PHARMACEUTICALS96.55%36 888
GENMAB-11.85%9 967
BLUEBIRD BIO INC199.68%8 385